Encompass Health Q4 Earnings Beat on Strong Discharge Growth
EHC expects adjusted EPS from continuing operations in the range of $4.67-$4.96 in 2025.
Encompass Health Corporation (EHC) Q4 2024 Earnings Call Transcript
Encompass Health Corporation (NYSE:EHC ) Q4 2024 Earnings Conference Call February 7, 2024 10:00 AM ET Corporate Participants Mark Miller - Chief Investor Relations Officer Mark Tarr - President and Chief Executive Officer Douglas Coltharp - Executive Vice President and Chief Financial Officer Conference Call Participants Whit Mayo - Leerink Partners Matthew Gilmore - KeyBanc A.J. Rice - UBS Andrew Mok - Barclays Joanna Gajic - Bank of America Ann Hynes - Mizuho Scott Fidel - Stephens Pito Chickering - Deutsche Bank Ben Hendrix - RBC Capital Markets Brian Tanquilut - Jefferies Jared Haase - William Blair Operator Good morning, everyone, and welcome to Encompass Health's Fourth Quarter 2024 Earnings Conference Call.
Encompass Health (EHC) Reports Q4 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Encompass Health (EHC) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Encompass Health (EHC) Beats Q4 Earnings and Revenue Estimates
Encompass Health (EHC) came out with quarterly earnings of $1.17 per share, beating the Zacks Consensus Estimate of $1.02 per share. This compares to earnings of $0.95 per share a year ago.
Stay Ahead of the Game With Encompass Health (EHC) Q4 Earnings: Wall Street's Insights on Key Metrics
Evaluate the expected performance of Encompass Health (EHC) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Here's Why Encompass Health (EHC) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Encompass Health is a Smart Addition to Your Portfolio
EHC is well-poised for growth on the back of robust demand for effective inpatient rehabilitation services, frequent expansion initiatives and solid cash reserves.
Are Investors Undervaluing Encompass Health (EHC) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
EHC vs. CHE: Which Stock Should Value Investors Buy Now?
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Encompass Health (EHC) and Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right now?
Wall Street Top Picks: 3 Healthcare Stocks Analysts Are Bullish About
The long-term outlook for the healthcare sector remains favorable, with profits expected to rise; analysts are bullish on THC, EHC and ENSG stocks.
Why Encompass Health (EHC) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Encompass Health (EHC) is a Top-Ranked Growth Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
